Turn Therapeutics Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
TTRX$9.92+1.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| (unaudited) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $3,106,157 | $872,599 |
| Prepaid expenses and other current assets | 188,583 | 225,325 |
| Total current assets | 3,294,740 | 1,097,924 |
| Right-of-use asset | 89,423 | 120,452 |
| Intangible assets, net | 904,885 | 821,931 |
| Security deposit | 8,582 | 8,582 |
| TOTAL ASSETS | $4,297,630 | $2,048,889 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $2,264,425 | $667,272 |
| Current portion of operating lease liability | 44,829 | 40,660 |
| Total current liabilities | 2,309,254 | 707,932 |
| Operating lease liability, net of current portion | 46,344 | 80,376 |
| Deferred revenue | 1,438,013 | 1,438,013 |
| TOTAL LIABILITIES | 3,793,611 | 2,226,321 |
| Commitments and contingencies (Note 9) | ||
| STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| Common Stock, $0.0001 par value, 500 million and 40 million shares authorized at September 30, 2025 and December 31, 2024, respectively; 28,022,826 and 26,845,690 shares issued at September 30, 2025 and December 31, 2024*, respectively | 2,802 | 2,685 |
| Additional paid-in capital | 23,223,079 | 19,015,896 |
| Subscription receivable | (52,699) | - |
| Accumulated deficit | (22,669,163) | (19,196,013) |
| Total stockholders’ equity (deficit) | 504,019 | (177,432) |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | $4,297,630 | $2,048,889 |
| * | Retroactively adjusted for 2-for-1 forward stock split. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.